These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25322075)

  • 41. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
    Vogelberg C; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Hamelmann E; Engel M; Szefler S
    Respir Res; 2015 Feb; 16(1):20. PubMed ID: 25851298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G; Williams DA; Weller P; Price JF
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
    Rabe KF; Timmer W; Sagkriotis A; Viel K
    Chest; 2008 Aug; 134(2):255-262. PubMed ID: 18403672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticholinergics for asthma: a long history.
    Rodrigo GJ
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):38-43. PubMed ID: 29040210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tiotropium for the treatment of adolescents with moderate to severe symptomatic asthma: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):211-6. PubMed ID: 26231467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current role of anticholinergic drugs in the treatment of asthma: key messages for clinical practice.
    Pizzichini MM; Kerstjens HA; Pizzichini E
    Pol Arch Med Wewn; 2015; 125(11):859-66. PubMed ID: 26529261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma.
    Snowise NG; Clements D; Ho SY; Follows RM
    Curr Med Res Opin; 2013 Dec; 29(12):1663-74. PubMed ID: 24010736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tiotropium bromide.
    Gross NJ
    Chest; 2004 Dec; 126(6):1946-53. PubMed ID: 15596697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and Safety of Tiotropium in the Treatment of Severe Persistent Asthma:Meta-analysis.
    Lou LL; Gong HH; Zhang MQ; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):62-8. PubMed ID: 26956858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of tiotropium Respimat
    Graham LM; Kerstjens HAM; Vogelberg C; Hamelmann E; Szefler SJ; Pisternick-Ruf W; Engel M; El Azzi G; Unseld A; Foggs MB
    Respir Med; 2019 Aug; 155():58-60. PubMed ID: 31302579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tiotropium in the treatment of patients with asthma.
    Rashid Q; Klein R
    South Med J; 2014 May; 107(5):330-7. PubMed ID: 24937736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic Effects of a Long-Acting Cholinergic Receptor Blocker, Tiotropium Bromide, on Asthma.
    Zhang L; Huang G; Jin L; Han S
    Med Sci Monit; 2018 Feb; 24():944-950. PubMed ID: 29446377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of tiotropium in treating patients with moderate-to-severe asthma: A meta-analysis and systematic review based on 14 randomized controlled trials.
    Meng JF; Li H; Luo MJ; Li HB
    Medicine (Baltimore); 2019 Aug; 98(33):e16637. PubMed ID: 31415357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asthma exacerbations and worsenings in patients aged 1-75 years with add-on tiotropium treatment.
    Mark FitzGerald J; Hamelmann E; Kerstjens HAM; Buhl R
    NPJ Prim Care Respir Med; 2020 Aug; 30(1):38. PubMed ID: 32868782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tiotropium in asthma: From bench to bedside.
    Mansfield L; Bernstein JA
    Respir Med; 2019; 154():47-55. PubMed ID: 31212121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging role of long-acting anticholinergics in children with asthma.
    Vogelberg C
    Curr Opin Pulm Med; 2016 Jan; 22(1):74-9. PubMed ID: 26606079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.